Journal
European Neuropsychopharmacology
Publication Date
2019
Volume
29
Issue
1
First Page
156
Last Page
170
Document Type
Open Access Publication
DOI
10.1016/j.euroneuro.2018.10.005
Rights and Permissions
Budde M, Friedrichs S, Alliey-Rodriguez N, Ament S, Badner JA, Berrettini WH, Bloss CS, Byerley W, Cichon S, Comes AL, Coryell W, Craig DW, Degenhardt F, Edenberg HJ, Foroud T, Forstner AJ, Frank J, Gershon ES, Goes FS, Greenwood TA, Guo Y, Hipolito M, Hood L, Keating BJ, Koller DL, Lawson WB, Liu C, Mahon PB, McInnis MG, McMahon FJ, Meier SM, Mühleisen TW, Murray SS, Nievergelt CM, Nurnberger JI Jr, Nwulia EA, Potash JB, Quarless D, Rice J, Roach JC, Scheftner WA, Schork NJ, Shekhtman T, Shilling PD, Smith EN, Streit F, Strohmaier J, Szelinger S, Treutlein J, Witt SH, Zandi PP, Zhang P, Zöllner S, Bickeböller H, Falkai PG, Kelsoe JR, Nöthen MM, Rietschel M, Schulze TG, Malzahn D. Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder. Eur Neuropsychopharmacol. 2019 Jan;29(1):156-170. doi: 10.1016/j.euroneuro.2018.10.005. © 2018 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-NDlicense.(http://creativecommons.org/licenses/by-nc-nd/4.0/)
Recommended Citation
Budde, Monika; Rice, John; and et al, "Efficient region-based test strategy uncovers genetic risk factors for functional outcome in bipolar disorder." European Neuropsychopharmacology. 29, 1. 156 - 170. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8283
Supplemental Material
